Skip to Primary Navigation Skip to Site Navigation Skip to Main Content

 

 




Evidence

Evidence

Prevention and Infusion Therapy. These studies have proven Tegaderm™ CHG Dressings not only provide better performance and support clinical best practices and facility protocols, but also help reduce skin flora†, a leading cause of CRBSIs.*

Reduces Skin Flora >

Proven to be as effective as, or better than BIOPATCH® at reducing skin flora on healthy adult subjects for up to 10 days.

Performs Better >

Rated better than BIOPATCH® plus cover dressing in overall performance.

Protects Better >

Tegaderm™ CHG Dressings serve as a barrier to organisms, including those most commonly associated with CRBSIs.*

Supports Best Practices and Protocols >

Integrated CHG and transparent dressing has “process built in” helping to improve compliance to facility protocol.

† in vivo on healthy adult subjects
*3M? Tegaderm? CHG Dressings have not been studied in a randomized clinical study as to their effectiveness in preventing CRBSIs.
BIOPATCH® is a registered trademark of ETHICON, INC.

Tegaderm™ CHG Dressing Logo

Request Information
Tagaderm™ CHG Dressing Clinical Evidence Package

Request your copy of the Tegaderm™ CHG Dressing Clinical Evidence Package and register to receive future product and educational program updates.


CHG packaging

Request more information about Independent individual facility experiences and their outcomes.


Live Chat
Live chat by BoldChat
Professional Resources
APIC SHEA
INS AVA
more >
Upcoming Events

AVA Annual
Scientific Meeting

Sept 24-26, 2010, National Harbor, MD

more >

Educational Resources

Learn more about IV site care, infection prevention strategies and other topics. CEUs available. >